Table 1:
Variable | HPV+ (n=62) | HPV− (n=26) | All Patients (n =88) | p-valuea |
---|---|---|---|---|
Age, years | 0.56 | |||
Median (IQR) | 74 (71–79) | 73 (71–77) | 73 (71–78) | |
Gender, n (%) | 0.36 | |||
Male | 47 (76) | 22 (85) | 69 (78) | |
Female | 15 (24) | 4 (15) | 19 (22) | |
Race/Ethnicity, n (%) | 0.007 | |||
White | 47 (76) | 11 (42) | 58 (66) | |
Black | 6 (10) | 7 (27) | 13 (15) | |
Other | 4 (6) | 1 (4) | 5 (6) | |
Hispanic | 5 (8) | 7 (27) | 12 (14) | |
Alcohol, n (%) | 0.007 | |||
Never/Moderate drinker | 54 (87) | 16 (62) | 70 (80) | |
Former Heavy drinker | 3 (5) | 7 (27) | 10 (11) | |
Current Heavy drinker | 5 (8) | 3 (12) | 8 (9) | |
Smoking, n (%) | 0.88 | |||
Never | 19 (31) | 7 (27) | 26 (30) | |
Former | 38 (61) | 16 (62) | 54 (61) | |
Current | 5 (8) | 3 (12) | 8 (9) | |
Smoking Pack Years, n (%) | 0.99 | |||
Never | 19 (31) | 7 (27) | 26 (30) | |
≤10 pack years | 11 (18) | 5 (19) | 16 (18) | |
10–≤20 pack years | 6 (10) | 3 (12) | 9 (10) | |
>20 | 26 (42) | 11 (42) | 37 (42) | |
ECOG, n (%) | 0.009 | |||
0 | 31 (50) | 6 (23) | 37 (42) | |
1 | 23 (37) | 12 (46) | 35 (40) | |
2 | 8 (13) | 5 (19) | 14 (16) | |
3 | 0 (0) | 3 (12) | 3 (3) | |
Charleston Comorbidity Index | 0.66 | |||
Median (IQR) | 6(5–7) | 6(5–7) | 6 (5–7) | |
Stage (AJCC 8th edition), n (%) | <.001 | |||
I | 23 (37) | 0 (0) | 23 (26) | |
II | 27 (44) | 4 (15) | 31 (35) | |
III | 12 (19) | 3 (12) | 15 (17) | |
IVA | 0 (0) | 10 (38) | 10 (11) | |
IVB | 0 (0) | 9 (35) | 9 (10) | |
Primary Site, n (%) | 0.04b | |||
Base of tongue | 35 (56) | 17 (65) | 52 (59) | |
Palatine Tonsils | 26 (42) | 6 (23) | 32 (36) | |
Other | 1 (2) | 3 (12) | 4 (5) | |
HPV subtype, n (%) | n=42 | <.001 | ||
16 | 35 (83) | N/A | 35 | |
18 | 2 (5) | 2 | ||
33 | 1 (2) | 1 | ||
35 | 4 (10) | 4 |
p-values relate to HPV+ versus HPV−
p-value=0.16 when other is not included in statistical analysis